These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35200568)

  • 1. Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
    Mireștean CC; Iancu RI; Iancu DPT
    Curr Oncol; 2022 Feb; 29(2):816-833. PubMed ID: 35200568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
    de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
    Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MicroRNAs in Prediction of Response to Radiotherapy in Head and Neck Cancer Patients - Pilot Study].
    Ahmad P; Slavík M; Šána J; Hermanová M; Šlampa P; Smilek P; Kazda T; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):137-139. PubMed ID: 29808687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiosensitivity and/or radioresistance of head and neck cancers: Biological angle].
    Guy JB; Rancoule C; Méry B; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
    Bull Cancer; 2016 Jan; 103(1):41-7. PubMed ID: 26702507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.
    Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O
    Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
    Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B
    Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.
    You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioresistance parameters in head and neck cancers and methods to radiosensitize].
    Biau J; Chautard E; Miroir J; Lapeyre M
    Cancer Radiother; 2015 Aug; 19(5):337-46; quiz 360-1, 363. PubMed ID: 26119219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.
    Kim SH; Lee WH; Kim SW; Je HU; Lee JC; Chang HW; Kim YM; Kim K; Kim SY; Han MW
    Cell Signal; 2018 Jul; 47():122-130. PubMed ID: 29653204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
    Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
    Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
    Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of predictive biomarkers to radiotherapy outcome through proteomics approaches].
    Lacombe J; Mange A; Azria D; Solassol J
    Cancer Radiother; 2013 Feb; 17(1):62-9; quiz 70, 72. PubMed ID: 23287796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of failure of radiotherapy in head and neck cancer.
    Peters LJ; Fletcher GH
    Radiother Oncol; 1983 Aug; 1(1):53-63. PubMed ID: 6680213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy resistance: identifying universal biomarkers for various human cancers.
    Larionova I; Rakina M; Ivanyuk E; Trushchuk Y; Chernyshova A; Denisov E
    J Cancer Res Clin Oncol; 2022 May; 148(5):1015-1031. PubMed ID: 35113235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients.
    Isayeva T; Brandwein-Gensler M; Somarathna M; Moore-Smith LD; Lee T
    Curr Pharm Des; 2017; 23(32):4729-4744. PubMed ID: 28571552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNA in head and neck cancer: current knowledge and perspectives.
    Courthod G; Franco P; Palermo L; Pisconti S; Numico G
    Molecules; 2014 May; 19(5):5704-16. PubMed ID: 24802984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.